Semler Scientific, INC

Semler Scientific, Inc. has been acquired by Strive, Inc., becoming a wholly-owned subsidiary, with Strive guaranteeing Semler's 4.25% Convertible Senior Notes due 2030.

Semler Scientific, Inc. stockholders approved the merger agreement with Strive, Inc. and related executive compensation at a special meeting on January 13, 2026.

Semler Scientific announces a 37% headcount reduction and cost-saving measures while providing supplemental disclosures for its pending all-stock merger with Strive, Inc.

Semler Scientific files supplemental unaudited pro forma financials for its all-stock acquisition by Strive, Inc., detailing combined financial outlook.

Semler Scientific announced a new Bitcoin dashboard for public disclosure and reported Q3 2025 BTC Yield, while also referencing a proposed merger with Strive Inc.

Strive, Inc. announced the closing of its initial public offering, raising $149.3 million, and significantly increased its Bitcoin holdings to approximately 7,525 BTC, ahead of its planned acquisition of Semler Scientific.

Semler Scientific reports a 45% revenue drop in its core healthcare business, offset by significant Bitcoin fair value gains, alongside a pending merger and major legal settlements.

Semler Scientific reported a significant increase in second-quarter net income driven by Bitcoin fair value gains, despite a sharp decline in healthcare revenues and a substantial litigation settlement charge.

Semler Scientific's Q1 2025 results reveal a net loss driven by decreased revenues due to CMS rate changes and a significant decrease in the fair value of bitcoin holdings.

Semler Scientific's Q3 2024 results show a decrease in revenue compared to the previous year, alongside a strategic move to adopt Bitcoin as its primary treasury reserve asset.

Semler Scientific's Q2 2024 results show a decrease in revenue and a net income of $11,000, impacted by pricing changes and a new bitcoin treasury strategy.

Semler Scientific's first quarter 2024 results show a decrease in revenue but an increase in net income compared to the same period last year.

Semler Scientific's 2024 annual report reveals increased net income driven by its healthcare technology solutions and strategic bitcoin investments.

Semler Scientific's 10-K filing details its capital stock, anti-takeover measures, and regulatory compliance, including ongoing efforts to expand the use of its QuantaFlo device.

Eric Semler, a director of Semler Scientific, Inc., reported the disposal of common stock and stock options following the company's merger with Strive, Inc. effective January 16, 2026.

Douglas Murphy-Chutorian, CEO of Semler Scientific, reported the disposal of common stock and conversion of stock options following the company's merger with Strive, Inc.

Director Daniel S. Messina's Semler Scientific shares and options were converted into Strive Class A common stock and options following the merger effective January 16, 2026.

Semler Scientific director Natalie Brunell's stock options were converted into Strive Class A common stock options following the merger effective January 16, 2026.

Semler Scientific Director William H. Chang reported the disposition of common stock and stock options following the company's merger with Strive, Inc., effective January 16, 2026.

Semler Scientific files an SEC Form 425 detailing a social media post regarding its proposed acquisition by Strive, Inc., and outlining associated risks and where to find further information.

Strive, Inc. and Semler Scientific, Inc. plan to combine in an all-stock merger, creating a leading Bitcoin treasury and asset management firm.

Semler Scientific is urging shareholders to cast their proxy votes, particularly on Proposal 4, which would enable the company to acquire Bitcoin.

Semler Scientific, Inc. filed a supplement to its definitive proxy statement for the 2025 Annual Meeting of Stockholders, primarily addressing meeting adjournment procedures.

Semler Scientific revised its agreement with Alliance Advisors to enhance proxy solicitation efforts for retail investors ahead of its 2025 annual meeting.

Semler Scientific seeks shareholder approval to significantly increase authorized shares to fund its ambitious Bitcoin accumulation strategy and long-term growth.

Semler Scientific, Inc. urges stockholders to approve proposals 3 and 4 to enable capital raising for its long-term Bitcoin acquisition strategy.

Semler Scientific, Inc. has completed its merger with Strive, Inc., becoming a wholly owned subsidiary, with Semler shareholders receiving Strive Class A Common Stock.

Semler Scientific, Inc. has completed its merger with Strive, Inc., becoming a wholly-owned subsidiary of Strive.

Weiss Asset Management LP, WAM GP LLC, and Andrew M. Weiss report no beneficial ownership of Semler Scientific, Inc. common stock as of March 31, 2026.

Weiss Asset Management LP, WAM GP LLC, and Andrew M. Weiss have reported a 5.2% beneficial ownership stake in Semler Scientific, Inc. as of December 31, 2025.

Ridgeback Capital Investments L.P., Ridgeback Capital Investments LLC, and Ridgeback Capital Management LLC have reported a complete divestment of their beneficial ownership in Semler Scientific, Inc.

A group of affiliated entities, including Capital Ventures International and Susquehanna Advisors Group, Inc., has reduced its beneficial ownership in Semler Scientific, Inc. to 2.6% of common stock.

Capital International Investors has reported a 2.6% beneficial ownership stake in Semler Scientific, Inc. as of September 30, 2025.

BlackRock, Inc. has reported a 5.7% passive ownership stake in Semler Scientific, Inc., holding 858,705 shares of common stock.